Protein arginine methyltransferase 5 promotes cholesterol biosynthesis mediated Th17 responses and autoimmunity
Protein arginine methyltransferase 5 promotes cholesterol biosynthesis mediated Th17 responses and autoimmunity
复制标题
DOI:
10.1172/jcl131254
复制
发表时间:
2020-04-01
影响因子:
15.9
通讯作者:
Guerau-de-Arellano, Mireia
中科院分区:
文献类型:
--
作者:
Webb, Lindsay M.;Sengupta, Shouvonik;Guerau-de-Arellano, Mireia
Protein arginine methyltransferase 5 (PRMT5) catalyzes symmetric dimethylation (SDM) of arginine, a posttranslational modification involved in oncogenesis and embryonic development. However, the role and mechanisms by which PRMTS modulates Th cell polarization and autoimmune disease have not yet been elucidated. Here, we found that PRMTS promoted SREBP1 SDM and the induction of cholesterol biosynthetic pathway enzymes that produce retinoid-related orphan receptor (ROR) agonists that activate ROR gamma t. Specific loss of PRMTS in the CD4+ Th cell compartment suppressed Th17 differentiation and protected mice from developing experimental autoimmune encephalomyelitis (EAE). We also found that PRMTS controlled thymic and peripheral homeostasis in the CD4(+) Th cell life cycle and invariant NK (iNK) T cell development and CD8(+) T cell maintenance. This work demonstrates that PRMTS expression in recently activated T cells is necessary for the cholesterol biosynthesis metabolic gene expression program that generates RORyt agonistic activity and promotes Th17 differentiation and EAE. These results point to Th PRMT5 and its downstream cholesterol biosynthesis pathway as promising therapeutic targets in Th17-mediated diseases.